Summary: Apollo Hospitals, Bharti Airtel conduct India’s first 5G/AI-guided colonoscopy and more briefings | Jobs Reply


Apollo Hospitals, Bharti Airtel Conducts First 5G/AI-Guided Colonoscopy Study

Apollo Hospitals and telecom company Bharti Airtel have started conducting the first 5G and AI-guided colonoscopy study in India.

The procedure was performed using AI on Airtel’s 5G technology, resulting in “much faster” and more accurate detection of colon cancer.

The study also leveraged Avesha’s edge inferencing applications on the Amazon Web Services platform to process data in real time, enabling faster analytics delivery.


Singapore health minister takes part in large-scale pop health study

A comprehensive population study on Asian-specific diseases has started in Singapore.

The project called SG100K aims to identify social, environmental, lifestyle and genetic factors associated with diseases such as diabetes, hypertension and cancer that are prevalent in Singapore.

Singapore’s Health Minister Ong Ye Kung joins the project as one of 100,000 consenting participants whose genomes will be sequenced and analyzed. Participants include people of Chinese, Malay and Indian backgrounds, who make up approximately 80% of the total population in Asia.

SG100K is being led by the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, in partnership with Singapore’s Precision Health Research and genomics technology company Illumina.


South Korea issues first approvals for innovative medical products

South Korea’s Ministries of Health and Welfare and Food and Drug Safety have approved the first three medical devices whose regulatory filings have been expedited under a new licensing system.

Two of the devices are digital therapeutics for treating insomnia by Welt and Aimmed and the other is an AI cerebral infarction diagnostic assistant software by JLK Bio.

At the end of October, the ministries formally designated devices based on AI/ML and digital wearable technologies as “ innovative medical devices that are now qualified for an accelerated approval process.


First APAC installation of NeuroLogica’s Next Generation Mobile Stroke Unit in Thailand

NeuroLogica, a subsidiary of Samsung Electronics, has started expanding its Mobile Stroke Unit with diagnostic CT imaging capabilities in Asia-Pacific with the first installation in Thailand.

The SmartMSU with OmniTom Elite was installed at Siriraj Stroke Center, Siriraj Hospital in Bangkok as part of the Mobile Stroke Unit-Stroke One Stop project.

According to a press release, the next-generation mobile stroke unit helps with early stroke detection by allowing paramedics to quickly assess if a patient is having a stroke caused by a blood clot or bleeding.



Source link